Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. 公共衛生學院
  3. 健康政策與管理研究所
Please use this identifier to cite or link to this item: https://scholars.lib.ntu.edu.tw/handle/123456789/109316
DC FieldValueLanguage
dc.contributor楊銘欽en
dc.contributor臺灣大學:醫療機構管理研究所zh_TW
dc.contributor.author璩大成zh
dc.contributor.authorChu, Da-Chenen
dc.creator璩大成zh
dc.creatorChu, Da-Chenen
dc.date2005en
dc.date.accessioned2007-11-28T04:38:55Z-
dc.date.accessioned2018-06-29T16:52:30Z-
dc.date.available2007-11-28T04:38:55Z-
dc.date.available2018-06-29T16:52:30Z-
dc.date.issued2005-
dc.identifierzh-TWen
dc.identifier.urihttp://ntur.lib.ntu.edu.tw//handle/246246/60091-
dc.description.abstract背景:由台灣一家遭受SARS嚴重院內感染的醫院人員受感染的情形,由醫院管理的角度,整理歸納出其與醫院環境、個人特性等之相關性,從而提供醫院內感染控制及管理之方針。 材料及方法:收集該院感染事件所有相關人員之身份、通報染SARS之罹病狀況及存歿等資料,分析所有相關人員之身份與通報染SARS之罹病狀況及存歿之相關性。以及收集醫院工作同仁之年齡、性別、工作樓層、職業別、工作單位等資料;分析醫院工作同仁被通報染SARS與健康同仁各變項之分佈狀況及相關性。另收集被通報染SARS同仁之通報日期、病毒抗原及抗體檢查結果及臨床判定等資料;分析被通報染SARS同仁各變項之間分佈狀況及相關性。另外對777位健康員工作SARS抗體之篩檢,以研究此族群之抗體陽性率,並對抗體陽性之同仁作半年及一年後之抗體追蹤。 結果:在該院感染事件所有相關人員1539人中,醫院員工976人(63.4%),外包人員38人(2.5%),病患和家屬366人(23.8%),以及外部支援人員159人(10.3%)。所有相關人員中,共有108人被通報,其中75人被判定為SARS可能病例,33人被判定為疑似病例,可能病例佔在院隔離人數之4.9﹪;共計25人死亡,包括被判定為SARS可能病例者24人死亡(可能病例個案死亡率32%),而被判為疑似病患者1人死亡。 在醫院工作同仁共1014人中,有62位被通報染SARS,平均年齡為36±9.9歲。以急診及B8病房發病人數最多,職業別以護理人員為最多;被通報染病與工作樓層、職業別、工作單位有顯著相關,與年齡及性別無關。 62位被通報染SARS同仁中,扣除抗體資料不全者後共59例,其中男性9位,女性50位;8人死亡;42人判定為可能病例(4.1%),17人(2.0%)判定為疑似病例。42位可能病例中,抗原陽性者有21位(50%),抗體陽性者有32位(76.2%);疑似病例17位中,抗原陽性者0位,抗體陽性者12位(70.6%)。抗原與職業別及通報日期具顯著相關性;抗體與性別具顯著相關性;臨床判定與職業別及通報日期具顯著相關性;存歿與工作單位及通報日期具顯著相關。抗原與存歿及臨床判定有相關性,但與抗體反應無相關性。抗體與存活有相關性,而與臨床判定無相關性。存歿與臨床判定之間不具相關性。 32位抗體陽性,而接受完整追蹤之同仁,半年後之抗體陽性率為100%,一年後之陽性率為69.4%。健康的員工中有4位抗體反應為陽性。 結論:SARS造成該院內健康照護者及病患高比率的罹病及死亡率。以抗原、抗體、存歿、臨床判定之間的不一致相關性而言,SARS之診斷仍需依靠臨床及實驗室數據的綜合判斷。各種個人特性及工作環境因素中,工作地點及通報日期,較明顯影響罹病。故應改善醫院的空間規劃及加強人員的教育訓練與管制,並在感染發生時,快速的展開疫調、隔離、個人防護等措施。病毒抗原PCR檢查之陽性率偏低,需作至少兩套以減少偽陰性。抗體檢查具高度靈敏性及特異性,適合作流行病學之調查。抗體會衰減消失。無症狀之醫院工作同仁可有陽性抗體反應。zh_TW
dc.description.abstractBackground. SARS was a severe infectious disease that caused marked damage worldwide. SARS also challenged the infection control system and hospital management. From the infectious condition of the persons in a hospital that was attacked by SARS, we analyzed the role of personal characteristics and environment on the infection control managements. Material and methods. The data about all the personns that were involved in the SARS infection of the hospital was collected, including the age, sex, working unit, working floor, and occupation. The result of antigen(PCR) and antibody studies, the mortality, the clinical classification of probable or suspect cases, and the time of being reported as infected, were collected from health care workers (HCWs) who were infected by SARS. The distribution and correlation among variables of the infected HCWs were analyzed. Seven hundred and seventy-seven asymptomatic HCWs received antibody survey about one month after the onset of the event to study the epidemiological of the nosocomial infection. Thirty-two HCWs received 3 times of antibody surveys follow up within one year. Result. There were 1539 persons involved in the SARS nosocomial infection, including 976 hospital employees (63.4%), 38 outsourcing employees (2.5%), 366 patients and their family members (23.8%), 159 members of rescue team from other institutes (10.3%). Totally 108 persons were reported as been infected, 75 (4.9% of all involved persons) were classified as probable and 33 were classified as suspect SARS patients. Twenty-four probable cases expired (case fatality rate 32%). Sixty-two colleagues were reported as infected among 1014 HCWs. Persons in ward B8 and emergency room as well as being nurses had the largest number of HCW being reported as the SARS victim. Reported cases were significantly correlated to working floor, occupation and working unit, and not correlated to age and sex. Fifty-nine colleagues that were reported and had complete data were further analyzed. There were 42 probable and 17 suspect cases. Among the 42 probable cases, 21 had positive PCR, 32 had positive antibody. Among the 17 suspect cases, none had positive PCR, 12 had positive antibody. Thirty-two colleagues who had initially positive antibody received followed up at 6 months interval. The result revealed a 100% of positive rate at 6 months, and a 69.4% positive rate at 12 months. There were 4 positive antibody results in the asymptomatic HCWs. Conclusion: SARS caused a high infection rate and mortality at the study hospital. Working unit and occupation significantly affected the infection rate. The environment control and the education about personal protection, as well as the improvement of ventilation system, are important measures to reduce the severity and the extend of nosocomial viral infection.en
dc.description.tableofcontents中文摘要………………………………………………………… Ⅱ 英文摘要………………………………………………………… Ⅴ 目錄……………………………………………………………… Ⅶ 表目錄…………………………………………………………… Ⅷ 圖目錄…………………………………………………………… X 壹、 前言………………………………………… 01 貳、 材料及方法………………………………… 05 參、 研究結果…………………………………… 09 肆、 討論………………………………………… 14 伍、 結論及建議………………………………… 23 陸、 參考資料…………………………………… 25 表及圖…………………………………………… 30zh_TW
dc.format.extent407672 bytes-
dc.format.mimetypeapplication/pdf-
dc.languagezh-TWen
dc.language.isoen_US-
dc.subject院內感染en
dc.subject工作環境en
dc.subject個人特性en
dc.subject醫院管理zh_TW
dc.subject感染控制en
dc.subject抗原en
dc.subject抗體en
dc.subjectSARSen
dc.subjectnosocomial infectionen
dc.subjecthospital managementen
dc.titleSARS院內感染中人員之感染狀況及其對醫院感染管控之啟示zh_TW
dc.titleCondition of Persons in a Hospital with SARS nosocomial infection and its Implications to Hospital Managements.en
dc.typethesisen
dc.identifier.uri.fulltexthttp://ntur.lib.ntu.edu.tw/bitstream/246246/60091/1/ntu-94-P92843017-1.pdf-
dc.relation.reference1. 疾病管制局(2003).台灣嚴重急性呼吸道症候群SARS防疫專刊。台北,疾病管制局。 2. Booth TF, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, Li Y, Spence M, Paton S, Henry B, Mederski B, White D, Low DE, McGeer A, Simor A, Vearncombe M, Downey J, Jamieson FB, Tang P, Plummer F.:Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis. 2005 1;191(9):1472-7. 3. Chan HL, Kwan AC, To KF, Lai ST, Chan PK, Leung WK, Lee N, Wu A, Sung JJ:Clinical significance of hepatic derangement in severe acute respiratory syndrome. World J Gastroenterol. 2005 Apr14;11(14):2148-53. 4. Chen CJ:SARS Outbreak and Social Reconstruction in Taiwan. International Conference on SARS and Social Reconstruction in Comparative Perspective.Taipei,Taiwan. March 17-18, 2005 5. Centers for Disease Control and Prevention (CDC): Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China. Morb Mortal Wkly Rep. (2003a )17;52(41):986-7. 6. CDC:Update: Outbreak of severe acute respiratory syndrome --worldwide, 2003. Morb Mortal Wkly Rep. (2003b) Mar 28; 52(12):241-6, 248. 7. CDC:Update: outbreak of severe acute respiratory syndrome--worldwide, 2003. Mortal Wkly Rep. 2003 Apr 4;52(13):269-72. 8. Chong WC, Tham KY, Goh HK, Seow E:Presentation of severe acute respiratory syndrome (SARS) patients in a screening centre. Singapore Med J. 2005 Apr;46(4):161-4. 9. Chu D, Su IJ, Huang LC, Lee SS, Hu BS, Tsai HJ, Fang YC , Chen HM, Wang TS, Ho MS:Epidemiological Investigative and Analytical Research on the SARS Infected Staff and Campus Blocking of Taipei Municipal Hoping Hospital. SARS in Taiwan -One Year After the Outbreak;Center for Disease Control,Department of Health,Taiwan,R.O.C Taiwan Urbani Foundation,R.O.C:47-53,2004 10. Chung BP, Wong TK, Suen ES, Chung JW.:SARS: caring for patients in Hong Kong.Clin Nurs. 2005 Apr;14(4):510-7. 11. Ho SM, Kwong-Lo RS, Mak CW, Wong JS:Fear of severe acute respiratory syndrome (SARS) among health care workers. Consult Clin Psychol. 2005 Apr;73(2):344-9. 12. Hsueh PR, Hsiao CH, Yeh SH, Wang WK, Chen PJ, Wang JT, Chang SC, Kao CL, Yang PC:Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis. 2003 Sep;9(9):1163-7. 13. Hsueh PR, Yang PC:Severe acute respiratory syndrome epidemic in Taiwan, 2003. J Microbiol Immunol Infect. 2005 Apr;38(2): 82-8. 14. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, Ko FW, Chan MC, Chan DP, Tong MW, Rainer TH, Ahuja AT, Cockram CS, Sung JJ:Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005 May;60(5):401-9. 15. Lam MF, Ooi GC, Lam B, Ho JC, Seto WH, Ho PL, Wong PC, Liang R, Lam WK, Tsang KW:An indolent case of severe acute respiratory syndrome.Am J Respir Crit Care Med. 2004 Jan 1;169(1):125-8. 16. Lan YC, Liu TT, Yang JY, Lee CM, Chen YJ, Chan YJ, Lu JJ, Liu HF, Hsiung CA, Ho MS, Hsiao KJ, Chen HY, Chen YM:Molecular epidemiology of severe acute respiratory syndrome-associated coronavirus infections in Taiwan. J Infect Dis. 2005 May 1;191(9):1478-89. 17. Lee CH, Huang N, Chang HJ, Hsu YJ, Wang MC, Chou YJ:The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan. BMC Public Health. 2005 Apr 4;5(1):30 18. Li LH, Shi YL, Li P, Xu DX, Wan GP, Gu XQ, Zhang XL, Ma QJ, Cao C:Detection and analysis of SARS coronavirus-specific antibodies in sera from non-SARS children. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1085-7. 19. Liu CY, Huang LJ, Lai CH, Chen HP, Chen TL, Fung CP, Liu CY.:Clinical characteristics, management and prognostic factors in patients with probable severe acute respiratory syndrome (SARS) in a SARS center in Taiwan. J Chin Med Assoc. 2005 Mar;68(3):110-7. 20. Liu Y, Wang Z, Deng YJ, Ni AP, Ma C, Wen J, Zhang SM, Liu D, Yuan XF, He W:Reliability of detecting SARS-CoV antibody for diagnosis of SARS. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. (2003a) Oct;2(5):539-41. 21. Liu YN, Fan BX, Fang XQ, Yu BX, Chen LA:The quantitative detection of anti-coronavirus antibody titer in medical personnel closely contacted with severe acute respiratory syndrome patients. Zhonghua Jie He He Hu Xi Za Zhi. (2003b )Oct;26(10):583-5. 22. Loh LC, Chelliah A, Ang TH, Ali AM:Change in infection control practices and awareness of hospital medical staff in the aftermath of SARS. Med J Malaysia. 2004 Dec;59(5):659-64. 23. Muller MP, Tomlinson G, Marrie TJ, Tang P, McGeer A, Low DE, Detsky AS, Gold WL.:Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis. 2005 Apr 15;40(8):1079-86. 24. Phua DH, Tang HK, Tham KY.:Coping responses of emergency physicians and nurses to the 2003 severe acute respiratory syndrome outbreak. Acad Emerg Med. 2005 Apr;12(4):322-8. 25. Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H,Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S:Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods. 2005 May;125(2):181-6. 26. Simmerman JM, Chu D.Chang H:Implications of unrecognized severe acute respiratory syndrome. Nurse Pract. 2004 Jan;29(1) 27. Teo P, Yeoh BS, Ong SN:SARS in Singapore: surveillance strategies in a globalising city. Health Policy. 2005 Jun;72(3):279-91. 28. Tsui KL, Li SK, Li MC, Chan KK, Leung TC, Tse TS, Chan CK, Lam KK, Yam LY:Preparedness of the cardiac catheterization laboratory for severe acute respiratory syndrome (SARS) and other epidemics. J Invasive Cardiol. 2005 Mar;17(3):149-52. 29. Wang HB, Liu JH, Ouyang XL, Yu Y, Ma SX, Li XJ, Lu LC, Tian YP, Liu HY, Xu HM, Yao W:Detection of the Anti-SARS-Coronavirus Specific Antibody Levels in 156 SARS Patients. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Oct;11(5):441-3. 30. Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, Yang Y, Qin E, You B, Li W, Li X, Huang S, Yang R, Zhang X, Yang L, Zhang T, Yin Y, Cui X, Tang X, Wang L, He B, Ma L, Lei T, Zeng C, Fang J, Yu J, Wang J, Yang H, West MB, Bhatnagar A, Lu Y, Xu N, Liu S:Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem. 2003 Dec;49(12):1989-96. 31. Wang YS, Shen H, Sun SH, Jiang LH, Liu Y, Zhu ZW, Xiao DJ, Huang P, Yang B, Du XY, Zhang YC:Analysis of false-positive associated with antibody tests for SARS-CoV in SLE patients. Shi Yan Sheng Wu Xue Bao. 2003 Aug;36(4):314-7. 32. Wong SY, Wong W, Jaakkimainen L, Bondy S, Tsang KK, Lee A:Primary care physicians in Hong Kong and Canada--how did their practices differduring the SARS epidemic?. Fam Pract. 2005 May 16. 33. Xu G, Lu H, Li J, Li Y, Feng Z, Hou N, Wang G, Zhao ZD, Zhang G,Yan C,Li H, Gao X, Xu X, Wang G,Zhuang H.:Primary investigation on the changing mode of plasma specific IgG antibody in SARS patients and their physicians and nurses. Beijing Da Xue Xue Bao. 2003 May 31;35 Suppl:23-5. 34. Yam WC, Chan KH, Poon LL, Guan Y, Yuen KY, Seto WH, Peiris JS.:Evaluation of reverse transcription-P CR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. Clin Microbiol. 2003 ct;41(10):4521-4. 35. Yam WC, Chan KH, Chow KH, Poon LL, Lam HY, Yuen KY, Seto WH, Peiris JS:Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. J Clin Virol. 2005 May;33(1):19-24. 36. Zhao J, Wang W, Wang GF, Li Y, Zhuang H, Xu X, Ren F, Zhao Z,Gao XM:Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. J Clin Virol. 2005 May;33(1):12-8. 37. Zhuang JH, Huang XZ, Zhou Q, Lin LY, Lin L:Dynamic observation IgG and IgM antibodies in patients with severe acute respiratory syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Oct;15(10):579-81.zh_TW
item.grantfulltextopen-
item.openairetypethesis-
item.fulltextwith fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_46ec-
item.languageiso639-1en_US-
item.cerifentitytypePublications-
Appears in Collections:健康政策與管理研究所
Files in This Item:
File Description SizeFormat
ntu-94-P92843017-1.pdf23.31 kBAdobe PDFView/Open
Show simple item record

Page view(s) 5

17
checked on Jul 19, 2020

Download(s) 5

1
checked on Jul 19, 2020

Google ScholarTM

Check

Related Items in TAIR


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback